897TiPA phase III randomized, placebo-controlled, double-blind study of niraparib plus abiraterone acetate and prednisone versus abiraterone acetate and prednisone in patients with metastatic prostate cancer (NCT03748641)
Chi, K N, Rathkopf, D, Attard, G, Smith, M R, Efstathiou, E, Olmos, D, Small, E J, Lee, J Y, Sieber, P, Dunshee, C, Ricci, D, Simon, J S, Zhao, X, Kothari, N, Cheng, S, Sandhu, S KVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz248.054
Date:
October, 2019
Fichier:
PDF, 75 KB
2019
File converter
Plus de résultats de recherche
More benefits 
